Clinical Trial Update: Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Diffuse Large B Cell Lymphoma [NA]

View source ↗

Summary

Clinical trial update on evaluating the efficacy and safety of CAR-T therapy for recurrent or refractory diffuse large B-cell lymphoma; the current trial status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: Sinobioway Cell Therapy Co., Ltd. | Conditions: Lymphoma | NA | Status: UNKNOWN